+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Companion Animal Postoperative Pain Management Therapeutics Market - Global Forecast 2026-2032- Product Image
Companion Animal Postoperative Pain Management Therapeutics Market - Global Forecast 2026-2032- Product Image
Sale

Companion Animal Postoperative Pain Management Therapeutics Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5337136
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Companion Animal Postoperative Pain Management Therapeutics Market is projected to reach USD 186.38 Million in 2026. It is expected to continue growing at a CAGR of 10.36%, reaching USD 328.45 Million by 2032.

Companion animal postoperative pain management therapeutics are moving from optional supportive care to a core standard of veterinary medicine. Surgical volumes across sterilization, orthopedics, dentistry, oncology, wound repair, and minimally invasive procedures continue to create sustained demand for safe analgesics, multimodal protocols, and clinic-ready pain assessment tools for dogs, cats, and other companion animals.

The landscape is shaped by evidence-based veterinary guidelines, rising pet humanization, broader pet insurance adoption in developed economies, and regulatory oversight from agencies such as the U.S. FDA Center for Veterinary Medicine, Health Canada, the European Medicines Agency, and national veterinary authorities. Demand is strongest where veterinarians can combine nonsteroidal anti-inflammatory drugs, opioids, local anesthetics, alpha-2 agonists, adjunctive agents, and nonpharmacologic recovery support into individualized, species-specific postoperative pain plans.

Transformative Shifts in the Postoperative Pain Management Landscape

The landscape is shifting toward multimodal analgesia, with veterinarians increasingly combining anti-inflammatory control, regional anesthesia, local anesthetic delivery, and rescue analgesia rather than relying on single-agent therapy. This shift is supported by AAHA, AAFP, WSAVA, and other veterinary bodies that emphasize routine pain scoring, preemptive analgesia, patient warming, comfort-focused handling, and reassessment throughout recovery.

Commercially, clinics are prioritizing therapeutics that improve compliance, reduce dosing errors, and support safe discharge after routine and advanced procedures. Long-acting injectable formulations, species-specific labeling, controlled-substance stewardship, and improved safety monitoring are becoming decisive differentiators. Manufacturers that align clinical evidence with workflow efficiency are positioned to capture value across general practice, specialty hospitals, emergency surgery settings, and home recovery programs.

Cumulative Impact of Artificial Intelligence on Pain Therapeutics

Artificial intelligence is beginning to influence companion animal postoperative pain management through decision support, image and video-based behavioral analysis, remote monitoring, and pharmacovigilance. AI-enabled systems can help detect changes in posture, mobility, appetite, vocalization, sleep, activity levels, and wound interference that may indicate inadequate analgesia after surgery, especially when pets recover at home.

The cumulative impact is not replacement of veterinary judgment, but better triage, earlier intervention, and more consistent documentation. Data-driven pain scoring, predictive adverse-event monitoring, and electronic medical record integration can support safer NSAID selection, opioid stewardship, dose review, and individualized recovery protocols. Adoption will depend on clinical validation, explainability, cybersecurity, interoperability, privacy safeguards, and clinician trust.

Key Regional Insights Across Global Veterinary Pain Therapeutics

North America remains a high-value region due to advanced veterinary infrastructure, strong pet ownership, high surgical caseloads, and reimbursement support from pet insurance. The United States and Canada benefit from established FDA and Health Canada pathways, specialty hospital networks, continuing veterinary education, and widespread use of multimodal analgesia. Latin America is expanding as Brazil and Mexico invest in companion animal care, though affordability, uneven clinic access, and variable distribution infrastructure continue to influence therapeutic uptake.

Europe is driven by stringent welfare standards, EMA-regulated product quality, antimicrobial and controlled-substance stewardship, and high awareness of postoperative pain control across the United Kingdom, Germany, France, Italy, Spain, and neighboring markets. Asia-Pacific is a fast-evolving opportunity as China, India, Japan, South Korea, Australia, and ASEAN economies combine urban pet ownership growth with rising veterinary service sophistication and greater demand for premium companion animal healthcare. The Middle East, led by GCC markets, shows premium clinic development and growing demand for advanced surgical recovery protocols, while Africa remains heterogeneous, with growth concentrated in urban centers where veterinary access, professional training, and pharmaceutical distribution are improving.

Key Group Insights for EU, G7, BRICS, ASEAN, GCC, and NATO Markets

The European Union is a regulatory and clinical benchmark for companion animal postoperative pain management therapeutics because of harmonized medicine oversight, animal welfare policy, pharmacovigilance requirements, and strong veterinary professional standards. G7 markets collectively represent premium veterinary innovation environments, supported by advanced referral hospitals, high disposable income, companion animal insurance awareness, and established veterinary pharmaceutical channels.

BRICS markets are increasingly important for volume expansion and long-term access, particularly as Brazil, China, and India scale companion animal services, urban clinics, and veterinary distribution networks, while Russia and South Africa present more complex access and infrastructure conditions. ASEAN shows rising demand through urbanization and pet ownership in markets such as Indonesia, Thailand, Vietnam, Malaysia, Singapore, and the Philippines. GCC countries are building premium veterinary infrastructure supported by high-income urban pet ownership, while NATO-aligned markets overlap substantially with North American and European demand centers where supply security, controlled-substance compliance, cold-chain resilience, and reliable medical logistics are strategic priorities.

Key Country Insights in Companion Animal Postoperative Pain Care

The United States leads in product availability, specialty care adoption, continuing education, and postoperative pain protocol standardization, while Canada benefits from strong veterinary governance, high companion animal health awareness, and growing pet insurance penetration. Mexico and Brazil are key Latin American growth markets, with Brazil standing out for its large companion animal population and expanding private veterinary sector, and Mexico supported by urban clinic development and cross-border exposure to North American care standards. In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain mature companion animal care ecosystems with strong attention to welfare, analgesic safety, and regulated medicine use, while Russia presents demand potential tempered by regulatory, currency, and supply-chain complexity.

China and India are major long-term opportunities as pet ownership, urban veterinary clinics, digital pet health engagement, and middle-class spending expand. Japan and South Korea demonstrate high expectations for premium pet healthcare, precise dosing, minimally invasive surgery, and safety-focused therapeutics. Australia is notable for strong veterinary standards, high companion animal ownership, and rapid uptake of evidence-based pain management across general and specialty practices, supported by professional guidance and owner willingness to invest in postoperative recovery quality.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically differentiated products that solve real postoperative workflow challenges: rapid onset, durable analgesia, clear species-specific dosing, low adverse-event burden, palatable or easy-to-administer formats, and compatibility with multimodal protocols. Investment in robust clinical trials, real-world evidence, pharmacovigilance, and labeling clarity will strengthen positioning with veterinarians, regulators, distributors, and pet owners.

Organizations should also build education-led commercialization models. Training on validated pain scoring, feline-safe analgesia, renal and hepatic risk screening, NSAID monitoring, opioid stewardship, local anesthetic techniques, and discharge compliance can increase therapeutic adoption. Strategic partnerships with veterinary schools, corporate hospital networks, digital monitoring platforms, diagnostic providers, and pet insurers can improve market access while reinforcing evidence-based standards of care.

Research Methodology for Evidence-Based Market Analysis

This executive summary is developed using secondary research from verified veterinary, regulatory, and industry sources, including animal health regulatory agencies, veterinary medical associations, peer-reviewed clinical literature, pharmacovigilance guidance, pet ownership reports, animal welfare frameworks, and public veterinary health resources. The analysis emphasizes approved therapeutic classes, clinical care standards, regional market drivers, regulatory considerations, and adoption barriers.

Insights are triangulated across supply-side indicators, veterinary practice trends, pet demographics, product labeling, prescribing standards, and regional healthcare infrastructure. The methodology avoids speculative market sizing, market share, and forecasting where current verified data are unavailable and focuses on defensible, evidence-backed interpretation relevant to manufacturers, distributors, veterinary hospitals, investors, insurers, and digital health partners.

Conclusion: Future Direction for Veterinary Postoperative Pain Management

Companion animal postoperative pain management therapeutics are entering a more evidence-driven, technology-enabled, and welfare-focused phase. Demand is supported by rising surgical care standards, pet owner expectations, and the clinical need to reduce complications associated with unmanaged pain, including delayed mobility, stress responses, reduced appetite, sleep disruption, wound interference, and prolonged recovery.

The strongest opportunities will belong to organizations that combine regulatory-quality therapeutics with practitioner education, validated monitoring tools, responsible controlled-substance practices, and regional market access strategies. As veterinary teams continue to adopt multimodal analgesia and objective pain assessment, postoperative pain management will remain a defining pillar of modern companion animal healthcare.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Companion Animal Postoperative Pain Management Therapeutics Market, by Drug Class
7.1. Introduction
7.2. Local Anesthetics
7.2.1. Bupivacaine
7.2.2. Lidocaine
7.3. Non-Steroidal Anti-Inflammatory Drugs
7.3.1. Carprofen
7.3.2. Deracoxib
7.3.3. Firocoxib
7.3.4. Meloxicam
7.4. Opioids
7.4.1. Buprenorphine
7.4.2. Fentanyl
7.4.3. Tramadol
8. Companion Animal Postoperative Pain Management Therapeutics Market, by Animal Type
8.1. Introduction
8.2. Cats
8.3. Dogs
8.4. Horses
9. Companion Animal Postoperative Pain Management Therapeutics Market, by Route Of Administration
9.1. Introduction
9.2. Injectable
9.3. Oral
9.4. Topical
10. Companion Animal Postoperative Pain Management Therapeutics Market, by Surgery Type
10.1. Introduction
10.2. Orthopedic Surgery
10.2.1. Fracture Repair
10.2.2. Joint Surgery
10.2.3. Ligament Repair
10.3. Soft Tissue Surgery
10.3.1. Spaying Neutering
10.3.2. Tumor Removal
10.3.3. Abdominal Surgery
10.4. Dental Surgery
10.4.1. Tooth Extraction
10.4.2. Periodontal Procedures
11. Companion Animal Postoperative Pain Management Therapeutics Market, by End User
11.1. Introduction
11.2. Veterinary Hospitals
11.3. Academic Veterinary Institutes
11.4. Home Care Settings
12. Companion Animal Postoperative Pain Management Therapeutics Market, by Distribution Channel
12.1. Introduction
12.2. Online Pharmacies
12.3. Offline Pharmacies
13. Companion Animal Postoperative Pain Management Therapeutics Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa
14. Companion Animal Postoperative Pain Management Therapeutics Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Companion Animal Postoperative Pain Management Therapeutics Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Ashish Life Science Pvt. Ltd.
17.2. Boehringer Ingelheim International GmbH
17.3. Century Pharmaceuticals Ltd.
17.4. Ceva Santé Animale S.A.
17.5. Dechra Pharmaceuticals PLC
17.6. Elanco Animal Health Incorporated
17.7. Fidelis Animal Health
17.8. Indian Immunologicals Limited
17.9. Intas Pharmaceuticals Ltd.
17.10. Merck & Co., Inc.
17.11. Norbrook Laboratories Limited
17.12. Phibro Animal Health Corporation
17.13. Richter Pharma AG
17.14. SAVA Vet
17.15. Vetoquinol S.A.
17.16. Virbac S.A.
17.17. Zoetis Inc.
17.18. Zomedica Corp
List of Figures
FIGURE 1. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025 VS 2032 (%)
FIGURE 7. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 17. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL LOCAL ANESTHETICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL LOCAL ANESTHETICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL LOCAL ANESTHETICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL BUPIVACAINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL BUPIVACAINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL BUPIVACAINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL LIDOCAINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL LIDOCAINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL LIDOCAINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL NON-STEROIDAL ANTI-INFLAMMATORY DRUGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL NON-STEROIDAL ANTI-INFLAMMATORY DRUGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL NON-STEROIDAL ANTI-INFLAMMATORY DRUGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL CARPROFEN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL CARPROFEN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL CARPROFEN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL DERACOXIB MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL DERACOXIB MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL DERACOXIB MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL FIROCOXIB MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL FIROCOXIB MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL FIROCOXIB MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL MELOXICAM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL MELOXICAM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL MELOXICAM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL OPIOIDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL OPIOIDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL OPIOIDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL BUPRENORPHINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL BUPRENORPHINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL BUPRENORPHINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL FENTANYL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL FENTANYL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL FENTANYL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL TRAMADOL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL TRAMADOL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL TRAMADOL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL CATS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL CATS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL DOGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL DOGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL HORSES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL HORSES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL HORSES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL ORAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL ORAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL FRACTURE REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL FRACTURE REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL FRACTURE REPAIR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL JOINT SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL JOINT SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL JOINT SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL LIGAMENT REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL LIGAMENT REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL LIGAMENT REPAIR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL SOFT TISSUE SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL SOFT TISSUE SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL SOFT TISSUE SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL SPAYING NEUTERING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL SPAYING NEUTERING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL SPAYING NEUTERING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL TUMOR REMOVAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL TUMOR REMOVAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL TUMOR REMOVAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL ABDOMINAL SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL ABDOMINAL SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL ABDOMINAL SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL DENTAL SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL DENTAL SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL DENTAL SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL TOOTH EXTRACTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL TOOTH EXTRACTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL TOOTH EXTRACTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL PERIODONTAL PROCEDURES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL PERIODONTAL PROCEDURES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL PERIODONTAL PROCEDURES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL ACADEMIC VETERINARY INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL ACADEMIC VETERINARY INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL ACADEMIC VETERINARY INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL OFFLINE PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL OFFLINE PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL OFFLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, 2017-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2017-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2017-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SOFT TISSUE SURGERY, 2017-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DENTAL SURGERY, 2017-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 125. NORTH AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 126. NORTH AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 127. NORTH AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, 2017-2032 (USD MILLION)
TABLE 128. NORTH AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2017-2032 (USD MILLION)
TABLE 129. NORTH AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2017-2032 (USD MILLION)
TABLE 130. NORTH AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 131. NORTH AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 132. NORTH AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 133. NORTH AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 134. NORTH AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SOFT TISSUE SURGERY, 2017-2032 (USD MILLION)
TABLE 135. NORTH AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DENTAL SURGERY, 2017-2032 (USD MILLION)
TABLE 136. NORTH AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 137. NORTH AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 138. LATIN AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 139. LATIN AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 140. LATIN AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, 2017-2032 (USD MILLION)
TABLE 141. LATIN AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2017-2032 (USD MILLION)
TABLE 142. LATIN AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2017-2032 (USD MILLION)
TABLE 143. LATIN AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 144. LATIN AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 145. LATIN AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 146. LATIN AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 147. LATIN AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SOFT TISSUE SURGERY, 2017-2032 (USD MILLION)
TABLE 148. LATIN AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DENTAL SURGERY, 2017-2032 (USD MILLION)
TABLE 149. LATIN AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 150. LATIN AMERICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 151. EUROPE COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 152. EUROPE COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 153. EUROPE COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, 2017-2032 (USD MILLION)
TABLE 154. EUROPE COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2017-2032 (USD MILLION)
TABLE 155. EUROPE COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2017-2032 (USD MILLION)
TABLE 156. EUROPE COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 157. EUROPE COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 158. EUROPE COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 159. EUROPE COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 160. EUROPE COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SOFT TISSUE SURGERY, 2017-2032 (USD MILLION)
TABLE 161. EUROPE COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DENTAL SURGERY, 2017-2032 (USD MILLION)
TABLE 162. EUROPE COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 163. EUROPE COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 164. MIDDLE EAST COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 165. MIDDLE EAST COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 166. MIDDLE EAST COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, 2017-2032 (USD MILLION)
TABLE 167. MIDDLE EAST COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2017-2032 (USD MILLION)
TABLE 168. MIDDLE EAST COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2017-2032 (USD MILLION)
TABLE 169. MIDDLE EAST COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 170. MIDDLE EAST COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 171. MIDDLE EAST COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 172. MIDDLE EAST COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 173. MIDDLE EAST COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SOFT TISSUE SURGERY, 2017-2032 (USD MILLION)
TABLE 174. MIDDLE EAST COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DENTAL SURGERY, 2017-2032 (USD MILLION)
TABLE 175. MIDDLE EAST COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 176. MIDDLE EAST COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 177. AFRICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 178. AFRICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 179. AFRICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, 2017-2032 (USD MILLION)
TABLE 180. AFRICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2017-2032 (USD MILLION)
TABLE 181. AFRICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2017-2032 (USD MILLION)
TABLE 182. AFRICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 183. AFRICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 184. AFRICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 185. AFRICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 186. AFRICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SOFT TISSUE SURGERY, 2017-2032 (USD MILLION)
TABLE 187. AFRICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DENTAL SURGERY, 2017-2032 (USD MILLION)
TABLE 188. AFRICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 189. AFRICA COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 190. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 191. ASEAN COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 192. ASEAN COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 193. ASEAN COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, 2017-2032 (USD MILLION)
TABLE 194. ASEAN COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2017-2032 (USD MILLION)
TABLE 195. ASEAN COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2017-2032 (USD MILLION)
TABLE 196. ASEAN COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 197. ASEAN COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 198. ASEAN COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 199. ASEAN COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 200. ASEAN COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SOFT TISSUE SURGERY, 2017-2032 (USD MILLION)
TABLE 201. ASEAN COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DENTAL SURGERY, 2017-2032 (USD MILLION)
TABLE 202. ASEAN COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 203. ASEAN COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 204. GCC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 205. GCC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 206. GCC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, 2017-2032 (USD MILLION)
TABLE 207. GCC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2017-2032 (USD MILLION)
TABLE 208. GCC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2017-2032 (USD MILLION)
TABLE 209. GCC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 210. GCC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 211. GCC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 212. GCC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 213. GCC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SOFT TISSUE SURGERY, 2017-2032 (USD MILLION)
TABLE 214. GCC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DENTAL SURGERY, 2017-2032 (USD MILLION)
TABLE 215. GCC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 216. GCC COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, 2017-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2017-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2017-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SOFT TISSUE SURGERY, 2017-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DENTAL SURGERY, 2017-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 230. BRICS COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 231. BRICS COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 232. BRICS COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, 2017-2032 (USD MILLION)
TABLE 233. BRICS COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2017-2032 (USD MILLION)
TABLE 234. BRICS COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2017-2032 (USD MILLION)
TABLE 235. BRICS COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 236. BRICS COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 237. BRICS COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 238. BRICS COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 239. BRICS COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SOFT TISSUE SURGERY, 2017-2032 (USD MILLION)
TABLE 240. BRICS COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DENTAL SURGERY, 2017-2032 (USD MILLION)
TABLE 241. BRICS COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 242. BRICS COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 243. G7 COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 244. G7 COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 245. G7 COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, 2017-2032 (USD MILLION)
TABLE 246. G7 COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2017-2032 (USD MILLION)
TABLE 247. G7 COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2017-2032 (USD MILLION)
TABLE 248. G7 COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 249. G7 COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 250. G7 COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 251. G7 COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 252. G7 COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SOFT TISSUE SURGERY, 2017-2032 (USD MILLION)
TABLE 253. G7 COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DENTAL SURGERY, 2017-2032 (USD MILLION)
TABLE 254. G7 COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 255. G7 COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 256. NATO COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 257. NATO COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 258. NATO COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, 2017-2032 (USD MILLION)
TABLE 259. NATO COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2017-2032 (USD MILLION)
TABLE 260. NATO COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2017-2032 (USD MILLION)
TABLE 261. NATO COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 262. NATO COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 263. NATO COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 264. NATO COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 265. NATO COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SOFT TISSUE SURGERY, 2017-2032 (USD MILLION)
TABLE 266. NATO COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DENTAL SURGERY, 2017-2032 (USD MILLION)
TABLE 267. NATO COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 268. NATO COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 269. GLOBAL COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 270. UNITED STATES COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 271. UNITED STATES COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2017-2032 (USD MILLION)
TABLE 272. UNITED STATES COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, 2017-2032 (USD MILLION)
TABLE 273. UNITED STATES COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2017-2032 (USD MILLION)
TABLE 274. UNITED STATES COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2017-2032 (USD MILLION)
TABLE 275. UNITED STATES COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 276. UNITED STATES COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 277. UNITED STATES COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 278. UNITED STATES COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 279. UNITED STATES COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SOFT TISSUE SURGERY, 2017-2032 (USD MILLION)
TABLE 280. UNITED STATES COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DENTAL SURGERY, 2017-2032 (USD MILLION)
TABLE 281. UNITED STATES COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 282. UNITED STATES COMPANION ANIMAL POSTOPERATIVE PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 20

Companies Mentioned

  • Ashish Life Science Pvt. Ltd.
  • Boehringer Ingelheim International GmbH
  • Century Pharmaceuticals Ltd.
  • Ceva Santé Animale S.A.
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Fidelis Animal Health
  • Indian Immunologicals Limited
  • Intas Pharmaceuticals Ltd.
  • Merck & Co., Inc.
  • Norbrook Laboratories Limited
  • Phibro Animal Health Corporation
  • Richter Pharma AG
  • SAVA Vet
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis Inc.
  • Zomedica Corp

Table Information

Report AttributeDetails
No. of Pages185
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 186.38 Million
Forecasted Market Value ( USD ) by 2032 $ 328.45 Million
Compound Annual Growth Rate10.3%
Regions CoveredGlobal
No. of Companies Mentioned18

Related Topics

Related Reports

Companion Animal Postoperative Pain Management Therapeutics - Global Strategic Business Report - Product Image

Companion Animal Postoperative Pain Management Therapeutics - Global Strategic Business Report

  • Report
  • 474 Pages
  • Global
From
Companion Animal Postoperative Pain Management Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Companion Animal Postoperative Pain Management Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Companion Animal Pharmaceuticals Market - Global Forecast 2026-2032 - Product Image

Companion Animal Pharmaceuticals Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Veterinary Pharmaceuticals Market - Global Forecast 2026-2032 - Product Image

Veterinary Pharmaceuticals Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Veterinary Pain Management Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type - Product Image

Veterinary Pain Management Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

  • Report
  • 120 Pages
  • Global
From

About the Companion Animal Postoperative Pain Management Therapeutics Market

Within the field of animal pharmaceuticals, the Companion Animal Postoperative Pain Management Therapeutics market encompasses a range of products and services designed to alleviate pain experienced by pets such as dogs, cats, and other domestic animals following surgical procedures. Pain management is a crucial element of postoperative care in veterinary medicine, not only to ensure the comfort of the companion animals but also to facilitate better healing and recovery outcomes. The market includes pharmaceuticals such as nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, alpha-2 agonists, and other analgesics tailored specifically for use in companion animals. These medications must be approved by regulatory authorities, adhering to safety and efficacy standards, before being prescribed by veterinarians. The development of these therapeutics is driven by advances in veterinary pharmacology, an increased understanding of pain mechanisms in animals, and the growing demand for high-quality postoperative care driven by pet owners' concern for the welfare of their animals. Some companies active in the Companion Animal Postoperative Pain Management Therapeutics market include Zoetis, Boehringer Ingelheim Vetmedica, Elanco, Merck Animal Health, and Vetoquinol. These companies are engaged in the research, development, and marketing of veterinary drugs and are key players in providing solutions to effectively manage pain in companion animals after surgical interventions. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.